Search
-
Are people finally returning to the office?
The number of people shifting from remote work to hybrid work has jumped, according to the Ipsos Consumer Tracker.
-
Shopping continues to bounce back to pre-pandemic levels
Fewer people say they have experienced shipping delays during holiday shopping, compared to 2021, according to data from the Ipsos Consumer Tracker
-
Data Dive: Gen Z women are struggling the most with stress, mental health issues
In five points, we break down how people around the world are dealing (or not) as the pandemic fades away, war grinds on and sticky inflation sticks around.
-
How to fill gaps in teen mental health and social media research
Growing up has never been easy — but the digital age makes it more complicated. Barb Solish, national director in the Office of Innovation at NAMI, thinks that when it comes to teen mental health, research is needed to get the full picture.
-
HISF-Ipsos Threat Index finds natural disasters seen as fastest-growing threat
Ipsos survey for the Halifax International Security Forum finds natural disasters are increasingly believed by global citizens to be a leading threat
-
Americans expect a COVID surge in winter
Three in five Americans (61%) think there will be a spike in COVID cases this winter, which is about flat from the same time last year, according to new data from the Ipsos Consumer Tracker.
-
Political Perspectives: Interviews & News
On a regular basis, Ipsos experts are invited to share our research data and insights. Click here for the latest in media news articles and interviews.
-
57% globally think their country is not doing enough to meet its infrastructure needs
People continue to recognise infrastructure’s ‘double dividend’ but see substantial room for improvement.
-
Ipsos Update – October 2023
Education, infrastructure, healthcare… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos teams around the world.
-
COVID is back. Is America tired?
Below are five charts on the state of COVID-19 and how Americans feel about the new bivalent COVID-19 vaccine